文献速递心脑血管急症重症综合管理与镇静镇痛

心脏骤停后全身炎症和内皮损伤水平与心血管功能障碍及血管升压药支持相关

Level of systemic inflammation and endothelial injury is associated with cardiovascular dysfunction and vasopressor support in post-cardiac arrest patients.
PubMed 文献 · Resuscitation · 2017-09-23
一句话结论在OHCA昏迷幸存者中,全身炎症(尤其IL-6)和内皮损伤标志物与血管升压药支持需求增加相关,IL-6与CVI的关联受TTM分组修饰。

该研究为Target Temperature Management(TTM)试验的事后分析,纳入单中心163例OHCA昏迷患者,随机分配至33°C或36°C目标温度管理24小时。在随机化时及骤停后24、48、72小时检测炎症标志物(IL-6、IL-10、降钙素原、TNF-α)和内皮标志物(血栓调节蛋白、sE-选择素、syndecan-1、VE-钙黏蛋白),并记录血流动力学参数和累积血管升压药指数(CVI)。结果显示IL-6在随机化时与MAP负相关(r=-0.19,p=0.03)、与HR正相关(r=0.29,p=0.0002),系列IL-6水平与24h(r=0.19,p=0.02)、48h(r=0.31,p=0.0001)、72h(r=0.39,p<0.0001)的CVI持续相关。多变量回归证实IL-6和TTM分组与48h CVI相关,IL-6、TNF-α和TTM分组与72h CVI相关。结论提示全身炎症和内皮损伤与血管升压药支持需求增加相关。

要点

  • OHCA昏迷幸存者中,随机化时IL-6水平与MAP负相关(r=-0.19,p=0.03)、与HR正相关(r=0.29,p=0.0002)。
  • IL-6水平与血管升压药支持持续相关:24h(r=0.19,p=0.02)、48h(r=0.31,p=0.0001)、72h(r=0.39,p<0.0001)的CVI。
  • 48h时血栓调节蛋白(r=0.23,p=0.004)和syndecan-1(r=0.27,p=0.001)与CVI相关;72h时除IL-10外所有炎症标志物和所有内皮标志物均与CVI相关。
  • 多变量回归调整混杂因素后,48h CVI与IL-6(β=0.2,95%CI 0.06-0.3,p=0.004)和TTM分组(TTM36:β=-0.5,95%CI -0.9至0.1,p=0.01)相关;72h CVI与IL-6(β=0.3,95%CI 0.03-0.6,p<0.0001)、TNF-α(β=-0.4,95%CI -0.5至0.2,p<0.0001)和TTM分组(TTM36:β=-0.4
  • 72小时内IL-6整体两倍升高(β=0.2,95%CI 0.1-0.3,p<0.0001)和IL-10整体两倍升高(β=-0.2,95%CI -0.3至0.06,p=0.005)与CVI显著相关;TTM分组修饰CVI与IL-6的交互作用(pinteraction=0.008),与IL-10无交互作用(pinteraction=0.23)。

适用人群与场景

  • 纳入:单中心163例OHCA后昏迷患者,来自Target Temperature Management(TTM)试验,随机分配至33°C或36°C目标温度管理24小时。

研究设计与关键结果

  • 研究类型:TTM试验的事后分析,单中心,样本量163例OHCA昏迷患者,随机分配至TTM 33°C或36°C 24小时。
  • 干预与对照:比较TTM 33°C与TTM 36°C两组,检测炎症标志物(IL-6、IL-10、降钙素原、TNF-α)和内皮标志物(血栓调节蛋白、sE-选择素、syndecan-1、VE-钙黏蛋白)在随机化时及骤停后24、48、72小时的水平,并记录HR、MAP和CVI。
  • 主要终点结果:随机化时IL-6与MAP负相关(r=-0.19,p=0.03)、与HR正相关(r=0.29,p=0.0002);IL-6与CVI在24h(r=0.19,p=0.02)、48h(r=0.31,p=0.0001)、72h(r=0.39,p<0.0001)持续相关。
  • 关键次要终点:48h时血栓调节蛋白(r=0.23,p=0.004)和syndecan-1(r=0.27,p=0.001)与CVI相关;72h时除IL-10外所有炎症标志物和所有内皮标志物均与CVI相关。
  • 多变量回归:48h CVI与IL-6(β=0.2,95%CI 0.06-0.3,p=0.004)和TTM分组(TTM36:β=-0.5,95%CI -0.9至0.1,p=0.01)相关;72h CVI与IL-6(β=0.3,95%CI 0.03-0.6,p<0.0001)、TNF-α(β=-0.4,95%CI -0.5至0.2,p<0.0001)和TTM分组(TTM36:β=-0.4,95%CI -0.8至0.1,p=0.008)相关;72小时内IL-6整体两倍升高(β=0.2,95%CI 0.1-0.3,p<0.0001)和IL-10整体两倍升高(β=-0.2,95%CI -0.3至0.06,p=0.005)与CVI显著相关。

证据类型、等级与局限

  • 证据类型:TTM试验的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在OHCA后昏迷患者中,IL-6水平升高与血管升压药支持需求增加相关,提示全身炎症可能参与心脏骤停后综合征的心血管功能障碍。
  • 内皮损伤标志物(血栓调节蛋白、syndecan-1)与血管升压药支持相关,提示内皮损伤可能在心脏骤停后综合征相关心血管功能障碍中起作用。
  • TTM分组(33°C vs 36°C)修饰IL-6与CVI的关联(pinteraction=0.008)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: Post-cardiac arrest syndrome (PCAS) is characterized by a sepsis-like inflammatory response and hemodynamic instability. We investigated the associations between systemic inflammation, endothelial damage and hemodynamic parameters including vasopressor support in patients with out-of-hospital cardiac arrest (OHCA).

METHODS: In this post-hoc study, we analysed data from 163 comatose patients included at a single center in the Target Temperature Management (TTM) trial, randomly assigned to TTM at 33°C or 36°C for 24h. Inflammatory biomarkers (interleukin (IL)-6, IL-10, procalcitonin and Tumor Necrosis Factor-α (TNF-α)) and endothelial biomarkers (thrombomodulin, sE-selectin, syndecan-1 and VE-cadherin) were measured at randomization and 24, 48 and 72h after OHCA. Corresponding hemodynamic status, heart rate (HR), mean arterial pressure (MAP) and Cumulative Vasopressor Index (CVI) was reported.

RESULTS: At randomization, level of IL-6 correlated negatively with MAP (r=-0.19, p=0.03) and positively with HR (r=0.29, p=0.0002). Serial IL-6 levels correlated consistently with CVI at 24h: (r=0.19, p=0.02) 48h: (r=0.31, p=0.0001) and 72h: (r=0.39, p<0.0001). Thrombomodulin (r=0.23, p=0.004) and syndecan-1 (r=0.27, p=0.001) correlated with CVI at 48h. All inflammatory markers excerpt IL-10 and all endothelial markers correlated with CVI at 72h. Multivariable regression models adjusting for potential confounders confirmed that IL-6 (β=0.2 (95% CI: 0.06-0.3), p=0.004) and TTM-group (TTM36: β=-0.5 (95% CI: -0.9 to 0.1), p=0.01) were associated with CVI at 48h. At 72h after OHCA, IL-6 (β=0.3 (95% CI: 0.03-0.6), p<0.0001), TNF-α (β=-0.4 (95% CI:- 0.5 to 0.2), p<0.0001) and TTM-group (TTM36: β=-0.4 (95% CI: -0.8 to 0.1), p=0.008) were associated with CVI. An overall two-fold increase in levels of IL-6 (β=0.2 (95% CI: 0.1-0.3), p<0.0001) and IL-10 (β=-0.2 (95% CI: -0.3 to 0.06), p=0.005) within 72h after OHCA were significantly associated with CVI. TTM-group modified the interaction between CVI and IL-6 (pinteraction=0.008), but not with IL-10 (pinteraction=0.23).

CONCLUSIONS: In comatose survivors after OHCA, increasing systemic inflammation and endothelial injury was associated with increased need of vasopressor support. Systemic inflammation, in particular IL-6, was consistently associated with vasopressor support, however endothelial injury may also play a role in PCAS associated cardiovascular dysfunction after OHCA.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Bro-Jeppesen J, Johansson PI, Kjaergaard J, et al. Level of systemic inflammation and endothelial injury is associated with cardiovascular dysfunction and vasopressor support in post-cardiac arrest patients. Resuscitation. 2017. PMID: 28947390. doi:10.1016/j.resuscitation.2017.09.019

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。